Search - tctmd.com

Displaying 41 - 60 of 101

Sort: Relevancy | Date

FDA Approves Next-Generation Watchman FLX Device for LAA Occlusion

News Daily News

FDA Approves Next-Generation Watchman FLX Device for LAA Occlusion

July 22, 2020

PINNACLE FLX: New-Generation Watchman Has High Closure Rates, Good Safety

News Conference News HRS 2020

PINNACLE FLX: New-Generation Watchman Has High Closure Rates, Good Safety

May 15, 2020

Embolization Coils May Be an Option for Leaks After LAA Occlusion

News Daily News

Embolization Coils May Be an Option for Leaks After LAA Occlusion

January 15, 2020

Cardioversion Without Anticoagulation Appears Safe in Patients With Watchman

News Daily News

Cardioversion Without Anticoagulation Appears Safe in Patients With Watchman

November 01, 2019

Reduced-Dose Rivaroxaban May Be an Option After LAA Occlusion, ADRIFT Hints

News Conference News ESC 2019

Reduced-Dose Rivaroxaban May Be an Option After LAA Occlusion, ADRIFT Hints

September 11, 2019

LAA Occluders, NOACs Provide Similar Outcomes in High-risk A-fib Patients: PRAGUE-17

News Conference News ESC 2019

LAA Occluders, NOACs Provide Similar Outcomes in High-risk A-fib Patients: PRAGUE-17

September 10, 2019

Meta-analysis Supports Surgical LAA Occlusion During Cardiac Surgery, but Flaws Found

News Daily News

Meta-analysis Supports Surgical LAA Occlusion During Cardiac Surgery, but Flaws Found

August 16, 2019

Amplatzer Amulet LAA Closure Device Reduces Stroke Through 2 Years: Global Registry

News Conference News EuroPCR 2019

Amplatzer Amulet LAA Closure Device Reduces Stroke Through 2 Years: Global Registry

May 31, 2019

PRAGUE-12: Surgical Ablation of A-fib During Cardiac Surgery Has Long-term Stroke Benefit

News Conference News HRS 2019

PRAGUE-12: Surgical Ablation of A-fib During Cardiac Surgery Has Long-term Stroke Benefit

May 20, 2019

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

News Conference News EuroPCR 2019

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

May 16, 2019

Device-Related Thrombus and LAA Closure: Rare but Dangerous

News Daily News

Device-Related Thrombus and LAA Closure: Rare but Dangerous

Yael L. Maxwell

May 09, 2019

Go With NOACs Over Warfarin in Most Cases: Updated A-fib Guidelines

News Daily News

Go With NOACs Over Warfarin in Most Cases: Updated A-fib Guidelines

January 29, 2019

DOACs Safe, Effective in A-fib Patients With Preexisting LAA Thrombus

News Daily News

DOACs Safe, Effective in A-fib Patients With Preexisting LAA Thrombus

October 04, 2018

Novel LAA Closure Device Shows Promise in Early Experience

News Conference News TCT 2018

Novel LAA Closure Device Shows Promise in Early Experience

September 22, 2018

Thrombus on the Watchman LAA Occluder Tied to Higher Stroke Risk

News Conference News HRS 2018

Thrombus on the Watchman LAA Occluder Tied to Higher Stroke Risk

May 14, 2018

TCTMD’s Top 10 Most Popular Stories for April 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for April 2018

April 30, 2018

Device Thrombus After LAA Closure Strongly Linked to Stroke in Real-World Registry

News Daily News

Device Thrombus After LAA Closure Strongly Linked to Stroke in Real-World Registry

April 03, 2018

‘Acceptable Safety’ for LAA Closure Seen in a Real-World, All-Comers Registry

News Conference News AHA 2017

‘Acceptable Safety’ for LAA Closure Seen in a Real-World, All-Comers Registry

November 22, 2017

Longer-term Outcomes of Watchman Reassure as Debate Continues Over How It Should Be Used

News Conference News TCT 2017

Longer-term Outcomes of Watchman Reassure as Debate Continues Over How It Should Be Used

November 02, 2017

Complications Spiked, Then Fell, After Initial Introduction of Watchman LAA Closure Device

News Daily News

Complications Spiked, Then Fell, After Initial Introduction of Watchman LAA Closure Device

October 12, 2017

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.